Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronary Risk Equivalent”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)Study completedNCT01516541
What this trial is testing

Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Who this might be right for
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Hoffmann-La Roche 2,220
Testing effectiveness (Phase 2)Study completedNCT00269048
What this trial is testing

SB-480848 In Subjects With Coronary Heart Disease

Who this might be right for
Atherosclerosis
GlaxoSmithKline 969
Not applicableStudy completedNCT03016936
What this trial is testing

MET: REevaluation for Perioperative cArdIac Risk (MET-REPAIR)

Who this might be right for
Non Cardiac Surgery
European Society of Anaesthesiology 15,000
Large-scale testing (Phase 3)Study completedNCT00551447
What this trial is testing

A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)

Who this might be right for
Coronary Disease
Organon and Co 616
Not applicableStudy completedNCT05686330
What this trial is testing

Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable (Apple Watch)

Who this might be right for
Atrial Fibrillation
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) 436
Testing effectiveness (Phase 2)Study completedNCT00353522
What this trial is testing

RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.

Who this might be right for
Coronary Heart Disease
Hoffmann-La Roche 135
Large-scale testing (Phase 3)Study completedNCT00685776
What this trial is testing

Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)

Who this might be right for
Coronary Heart Disease (CHD)CHD Risk-Equivalent Disease
Merck Sharp & Dohme LLC 1,623
Not applicableEnded earlyNCT01357408
What this trial is testing

Heart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL Parameters

Who this might be right for
Heart Failure
Thomas Jefferson University 40
Large-scale testing (Phase 3)Study completedNCT00653588
What this trial is testing

Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks

Who this might be right for
HypercholesterolemiaCoronary Heart Disease
AstraZeneca
Post-approval studies (Phase 4)Active Not RecruitingNCT06249165
What this trial is testing

VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Duke University 130
Not applicableLooking for participantsNCT03987633
What this trial is testing

EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality

Who this might be right for
Atrial FibrillationCoronary Heart DiseaseCardiovascular Diseases+19 more
Future Genetics Limited 200,000
Not applicableStudy completedNCT01083914
What this trial is testing

Comparing Blood Loss, RBC Transfusions and Inflammatory Marker Changes Among Methods of CPB

Who this might be right for
Coronary Artery Disease
Baylor Research Institute 102
Not applicableStudy completedNCT00360217
What this trial is testing

The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes

Who this might be right for
Hypertriglyceridemia (TG>200<500)HyperlipidemiaCoronary Artery Disease+2 more
Maine Center for Lipids and Cardiovascular Health 60
Not applicableStudy completedNCT05355948
What this trial is testing

A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke

Who this might be right for
Atrial Fibrillation/Flutter in Patients With High Risk of Stroke
Yonsei University 1,000
Large-scale testing (Phase 3)Ended earlyNCT00134264
What this trial is testing

A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease

Who this might be right for
Coronary DiseaseDiabetes Mellitus
Pfizer 15,067
Testing effectiveness (Phase 2)Study completedNCT00655538
What this trial is testing

A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients

Who this might be right for
Coronary Heart Disease
Hoffmann-La Roche 476